Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TRIM29 anticorps (AA 1-200)

TRIM29 Reactivité: Humain WB Hôte: Souris Monoclonal TRIM29-1042 unconjugated
N° du produit ABIN6938676
  • Antigène Voir toutes TRIM29 Anticorps
    TRIM29 (Tripartite Motif Containing 29 (TRIM29))
    Épitope
    • 23
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200
    Reactivité
    • 63
    • 9
    • 8
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 31
    • 31
    • 1
    Souris
    Clonalité
    • 34
    • 29
    Monoclonal
    Conjugué
    • 37
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TRIM29 est non-conjugé
    Application
    • 38
    • 24
    • 21
    • 17
    • 13
    • 8
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    It recognizes a 66 kDa protein, which is identified as Tripartite motif-containing protein 29 (TRIM29). It interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA. High expression of TRIM29 has been reported in gastric cancer and pancreatic cancer, and correlates with enhanced tumor growth and lymph node metastasis. TRIM29 is also able to distinguish lung squamous cell carcinoma from lung adenocarcinoma with ~90 % positive accuracy, when used in a panel with TTF-1, p63, CK5/6, and Napsin-A antibodies.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant fragment (126 Amino acid residues between aa 1-200) of human TRIM29 protein
    Clone
    TRIM29-1042
    Isotype
    IgG2b kappa
    Top Product
    Discover our top product TRIM29 Anticorps primaire
  • Indications d'application

    Known_Application: Western Blot (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Positive_Control: A431 cells. Tonsil or Squamous cell carcinoma.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    TRIM29 (Tripartite Motif Containing 29 (TRIM29))
    Autre désignation
    TRIM29 (TRIM29 Produits)
    Synonymes
    anticorps ATDC, anticorps 1110047J21Rik, anticorps 2810431N19Rik, anticorps 4732461M22Rik, anticorps AI119726, anticorps MGC53484, anticorps TRIM29, anticorps atdc, anticorps tripartite motif containing 29, anticorps tripartite motif-containing 29, anticorps tripartite motif containing 29 L homeolog, anticorps TRIM29, anticorps Trim29, anticorps trim29.L, anticorps trim29
    Sujet
    Ataxia telangiectasia group D complementing gene (ATDC), Tripartite motif-containing protein 29 (TRIM29),TRIM29 (Lung Squamous Cell Carcinoma Marker)
    Cellular localisation: Cytoplasmic & Cell Surface
    Poids moléculaire
    66kDa
    ID gène
    23650, 504115
    UniProt
    Q14134
    Pathways
    Signalisation p53, Apoptose, Réparation de l'ADN, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Vous êtes ici:
Support technique